No quarterly revenue total was found in GLUCOSE HEALTH, INC.'s SEC filings.
Glucose Health, Inc. (GLUC) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products.
Revenue
—
Net income
$18,769
+111.7% vs year-ago quarter
Operating cash flow
$-1,677
-102.7% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
4.55M
+37.2% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- GLUC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bentonville, AR
- SEC filer status
- Smaller reporting company
- SEC CIK
- 1420108
- Former names
- Bio-Solutions Corp. (until Dec 16, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2017 Sep 30, 2017 |
Q2 FY2017 Jun 30, 2017 |
Q1 FY2017 Mar 31, 2017 |
Q4 FY2016 Dec 31, 2016 |
Q3 FY2016 Sep 30, 2016 |
|---|---|---|---|---|---|
| Operating income | $4,635 | $16,077 | -$28,313 | -$24,848 | -$55,556 |
| Net income | $18,769 | $49,258 | -$29,009 | -$124,080 | -$160,819 |
| Operating cash flow | -$1,677 | -$695 | -$11,534 | -$3,347 | $61,866 |
| Total assets | $26,353 | $27,318 | $18,865 | $33,145 | $43,962 |
| Total liabilities | $452,585 | $476,607 | $542,431 | $528,592 | $417,594 |
| Stockholders' equity | -$426,232 | -$449,289 | -$523,566 | -$495,447 | -$373,632 |
| Cash and investments | $16,636 | $18,313 | $9,008 | $20,542 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 14, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 21, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 15, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Auditor change
|
Apr 11, 2017 | Apr 6, 2017 |
| 10-K | Annual report | Mar 29, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Dec 21, 2016 | Sep 30, 2016 |
All 140 Glucose Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.